© 1996 by Oxford University Press
Journal of the National Cancer Institute, Vol. 88, No. 8, 510-518,
April 17, 1996
© 1996 Oxford University Press
Potential Role of the Inactivated X Chromosome in Ovarian Epithelial Tumor Development
Department of Gynecologic Oncology, Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern California Los Angeles
Department of Pathology, Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern California Los Angeles
Correspondence to: Louis Dubeau, M.D., Ph.D., Kenneth Norris Jr. Comprehensive Cancer Center, 1441 Eastlake Ave., Los Angeles, CA 90033.
BACKGROUND:: Ovarian epithelial tumors can be divided into subcategories often regarded as different stages of neoplastic transformation. Cystadenomas belong to the least aggressive subgroup and are noninvasive and nonmetastatic. Ovarian tumors of low malignant potential (LMP) are intermediate between cystadenomas and carcinomas and show markedly reduced invasive and metastatic abilities. Invasion and metastasis are the hallmarks of carcinomas, which constitute the most aggressive subgroup and can be further subdivided into different grades.
PURPOSE:: We performed comparative allelotype analyses of ovarian cystadenomas, LMP tumors, and carcinomas, reasoning that such analyses could provide clues about the molecular determinants of their phenotypic differences. Because we realized that allelic losses involving the X chromosome might be associated with LMP tumor development, we determined whether such losses were interstitial and whether they involved the active or the inactive X chromosome.
METHODS:: Frequencies of loss of heterozygosity (LOH) at specific loci in every chromosomal arm were determined in 16 ovarian cystadenomas, 23 ovarian LMP tumors, 15 low-grade ovarian carcinomas, and 35 high-grade ovarian carcinomas by use of either the polymerase chain reaction (PCR) or Southern blot analyses. We took advantage of the fact that DNA methylation is an important mechanism of X-chromosome inactivation to determine whether losses involving the X chromosome were in the active or the inactive copy. We analyzed the methylation status of retained alleles on the X chromosome by determining whether they could be amplified by PCR after digestion with the methylation-sensitive restriction endonuclease Hpa II.
RESULTS:: High-grade carcinomas contained frequent (>50%) LOH in four autosomal chromosome arms, i.e., 6q, 13q, 17p, and 17q. Except for 13q, these same chromosomal arms showed frequent LOH in low-grade carcinomas. LOH in autosomal chromosomes was comparatively rare in LMP tumors and was absent in cystadenomas. In contrast, half (eight of 16) of LMP tumors informative for a locus in the proximal portion of chromosome Xq showed LOH at that locus. These losses were the result of interstitial deletions in six of the eight cases and involved the inactive copy of the X chromosome exclusively. Similar losses in the X chromosome were not seen in either cystadenomas or low-grade carcinomas. Conclusions and Implications: LOH at multiple loci is associated with the development of ovarian carcinomas but not with the development of cystadenomas and LMP tumors. However, the integrity of a locus in chromosome Xq that possibly escapes X-chromosome inactivation is important for the control of LMP tumor development. The fact that this locus does not appear to be involved in the genesis of low-grade carcinomas suggests that LMP tumors are not precursors of such carcinomas. [J Natl Cancer Inst 1996;88:510–8]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Nakopoulou, E. G Panayotopoulou, I. Giannopoulou, I. Tsirmpa, S. Katsarou, E. Mylona, P. Alexandrou, and A. Keramopoulos Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis J. Clin. Pathol., July 1, 2007; 60(7): 808 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. L. Pon, N. Auersperg, and A. S. T. Wong Gonadotropins Regulate N-cadherin-mediated Human Ovarian Surface Epithelial Cell Survival at Both Post-translational and Transcriptional Levels through a Cyclic AMP/Protein Kinase A Pathway J. Biol. Chem., April 15, 2005; 280(15): 15438 - 15448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Brinkmann, A. Ryan, A. Ayhan, W. G. McCluggage, R. Feakins, M. F. Santibanez-Koref, C. A. Mein, S. A. Gayther, and I. J. Jacobs A Molecular Genetic and Statistical Approach for the Diagnosis of Dual-Site Cancers J Natl Cancer Inst, October 6, 2004; 96(19): 1441 - 1446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. O. Indsto, N. T. Nassif, R. F. Kefford, and G. J. Mann Frequent Loss of Heterozygosity Targeting the Inactive X Chromosome in Melanoma Clin. Cancer Res., December 15, 2003; 9(17): 6476 - 6482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A P M Jongsma, J M J Piek, R P Zweemer, R H M Verheijen, J W T Klein Gebbinck, G J van Kamp, I J Jacobs, P Shaw, P J van Diest, and P Kenemans Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer Mol. Pathol., October 1, 2002; 55(5): 305 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-C. Huang, P. H. Rao, C. C. Lau, E. Heard, S.-K. Ng, C. Brown, S. C. Mok, R. S. Berkowitz, and S.-W. Ng Relationship of XIST Expression and Responses of Ovarian Cancer to Chemotherapy Mol. Cancer Ther., August 1, 2002; 1(10): 769 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Manderson, A.-M. Mes-Masson, J. Novak, P. D. Lee, D. Provencher, T. J. Hudson, and P. N. Tonin Expression Profiles of 290 ESTs Mapped to Chromosome 3 in Human Epithelial Ovarian Cancer Cell Lines Using DNA Expression Oligonucleotide Microarrays Genome Res., January 1, 2002; 12(1): 112 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. O. Indsto, A. R. Cachia, R. F. Kefford, and G. J. Mann X Inactivation, DNA Deletion, and Microsatellite Instability in Common Acquired Melanocytic Nevi Clin. Cancer Res., December 1, 2001; 7(12): 4054 - 4059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Gardner and M. J. Birrer Ovarian Tumors of Low Malignant Potential: Can Molecular Biology Solve This Enigma? J Natl Cancer Inst, August 1, 2001; 93(15): 1122 - 1123. [Full Text] [PDF]
|
|
|
|
|
|
J. Gu, L. M. Roth, C. Younger, H. Michael, F. W. Abdul-Karim, S. Zhang, T. M. Ulbright, J. N. Eble, and L. Cheng Molecular Evidence for the Independent Origin of Extra-ovarian Papillary Serous Tumors of Low Malignant Potential J Natl Cancer Inst, August 1, 2001; 93(15): 1147 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Buller, A. K. Sood, T. Lallas, T. Buekers, and J. S. Skilling Association Between Nonrandom X-Chromosome Inactivation and BRCA1 Mutation in Germline DNA of Patients With Ovarian Cancer J Natl Cancer Inst, February 17, 1999; 91(4): 339 - 346. [Abstract] [Full Text] [PDF]
|
|